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The  hypolipidemic  activity  of friedelin  isolated  from  Azima  tetracantha  Lam.,  Salvadoraceae,  was  studied
in Triton  WR-1339  and  high-fat  diet-induced  hyperlipidemic  rats.  In Triton  WR-1339  induced  hyper-
lipidemic  rats,  treatment  with  friedelin  (50  and  70 mg/kg)  showed  a signiﬁcant  (p  < 0.01)  lipid-lowering
effect  as  assessed  by reversal  of plasma  levels  of total  cholesterol  (TC),  triacylglycerides  (TG),  high-densityeywords:
riedelin
igh-fat diet model
riton WR-1339
yperlipidemia
lipoprotein  cholesterol  (HDL-C)  and  low-density  lipoprotein  cholesterol  (LDL-C).  In high-fat  diet  fed
hyperlipidemic  rats,  treatment  with friedelin  (50 and  70  mg/kg)  caused  lowering  of  lipid  levels in  plasma
and liver.  The  hypolipidemic  activity  of  friedelin  was  compared  with  fenoﬁbrate,  a known  lipid-lowering
drug,  in both  models.
©  2015  Sociedade  Brasileira  de  Farmacognosia.  Published  by Elsevier  Editora  Ltda.  All  rights  reserved.
enoﬁbrate
ntroduction
Hyperlipidemia is a disorder characterized by increase in blood
ipoprotein or cholesterol levels. It is the major cause of car-
iovascular diseases, such as coronary heart disease, ischemic
erebrovascular disease, and peripheral vascular disease (Baby and
nuradha, 2013; Li et al., 2010). These diseases are the major
auses of mortality and morbidity worldwide. Approximately 12
illion people reportedly die of cardiovascular disease each year
orldwide (Sunil et al., 2012). Experimental and epidemiologi-
al studies have demonstrated that excess low-density lipoprotein
LDL) deposited in the artery wall is an important risk factor in
he initiation and progression of atherosclerotic impasse (Basuny
t al., 2012). The known lipid-lowering drugs (ﬁbrates, statins, bile
cid sequestrants, etc.) regulate the lipid metabolism by different
echanisms, but they also have many side effects like hyper-
ricemia, diarrhea, nausea, severe muscle damage (myopathy),
astric irritation, ﬂushing, dry skin and abnormal liver function
Sagar et al., 2012). Therefore, the development of lipid-lowering
∗ Corresponding author at: Research Centre for Plant Growth and Development,
chool of Life Sciences, University of KwaZulu-Natal, Pietermaritzburg, South Africa.
E-mail: christudass@ukzn.ac.za (C. Sunil).
http://dx.doi.org/10.1016/j.bjp.2015.07.025
102-695X/© 2015 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editoradrugs from natural sources is the best option and is in great demand.
A number of plants have been used traditionally for the treatment
of various cardiovascular diseases. World ethanobotanical infor-
mation reported that a number of herbal medicines from plants
and vegetables are used for controlling hyperlipidemia (Stephen
Irudayaraj et al., 2013). Therefore, efforts to develop effective
hypolipidaemic drugs have led to discovery of natural products for
the regulation of altered lipids.
Azima tetracantha Lam., Salvadoraceae, is known as ‘Mulsangu’
in Tamil and ‘Kundali’ in Sanskrit. Its root, root bark and leaves are
used with food as a remedy for rheumatism (Kirtikar et al., 1984;
Duraipandiyan et al., 2010). It is a powerful diuretic; it is used to
treat dropsy, dyspepsia, chronic diarrhea, cough, phthisis, asthma,
and small pox (Nargis Begum et al., 2009). The leaf extracts of A.
tetracantha showed in vitro antioxidant and free radical scaveng-
ing activities (Thendral Hepsibha et al., 2011). Azimine, azecarpin,
carpine, narcissoside, friedelin, lupeol, glutinol and -sitosterol
(Natarajan et al., 2014) are the isolated compounds from the leaves.
It showed good anti-inﬂammatory, analgesic and antipyretic prop-
erties on various animal models (Antonisamy et al., 2011). Jiao
et al. (2007) reported the antihyperlipidemic effect of friedelin from
bamboo shavings. This study aimed to investigate the hypolipi-
demic activity of friedelin isolated from the leaves of A. tetracantha
in Triton WR-1339 and high-fat diet-induced hyperlipidemic
rats.
 Ltda. All rights reserved.
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aterials and methods
rugs and chemicals
Triton WR-1339 was obtained from Sigma Chemical Co. (St
ouis, MO,  USA). Fenoﬁbrate was purchased from Ranbaxy, India.
iochemical kits and all other chemicals were of analytical grade.
riedelin identiﬁcation and characterization
Isolation and characterization of friedelin (1) from the leaves of
zima tetracantha has been previously reported (Antonisamy et al.,
011).
O
1
nimals
Male Wistar rats (180–200 g) were reared at Entomology
esearch Institute. The animals were kept in polypropylene cages,
nder controlled temperature, humidity and 12/12 light/dark
ycles. The animals were fed pellet diet (Pranav Agro Industries
td., Maharashtra) and water ad libitum. This study was carried out
ith prior approval from Institutional Animal Ethical Committee
IAEC-ERI-LC-28).
cute toxicity study
The doses for the study were ﬁxed based on Irwin test (Roux
t al., 2004). Five groups of fasted healthy rats (six per group) were
rally administered friedelin at a dose of 300, 400, 500, 600 and
00 mg/kg; the control group was given distilled water. The rats
ere observed for 1 h continuously and then hourly for 4 h and
nally after every 24 h up to 14 days for any physical signs of toxic-
ty, such as writhing, gasping, palpitation and decreased respiratory
ate or mortality. On the 15th day the animals were sacriﬁced and all
he organs were observed for gross pathological lesions. Friedelin
t these doses did not show any abnormal behavior. No treatment
elated gross pathological lesions were observed (data not shown).
/10th–1/20th of the dose, in which no behavioral alterations were
bserved, was considered safe for further assays. Hence, doses of 30,
0 and 70 mg/kg b wt. were preferred for subsequent experiments
ased on Oliveira et al. (2008).
ffect of friedelin on Triton WR-1339-induced hyperlipidemic rats
nduction of hyperlipidemia
To investigate the short-term effects of friedelin (1) on triton-
nduced hyperlipidemic rats, male Wistar rats weighing 160–180 g
ere used in the study. The hyperlipidemia was  induced by
ntraperitoneal injection of Triton WR-1339 (200 mg/kg) dissolved
n phosphate buffered saline (pH 7.4) (Levine and Saltzman, 2007).
Overnight fasted rats were divided into six groups of six each.
roup I served as normal control rats treated with vehicle; Groups
I–VI were given intraperitoneal injection of Triton WR 1339.de Farmacognosia 26 (2016) 89–93
Group II hyperlipidemic rats were treated with vehicle alone;
Group III–V hyperlipidemic rats were treated with friedelin 30,
50 and 70 mg/kg, respectively; Group VI hyperlipidemic rats were
treated with fenoﬁbrate (65 mg/kg) (Harnaﬁ et al., 2007). Friedelin
(dissolved in 1% tween 80) and fenoﬁbrate were given orally, imme-
diately after triton injection. In the following period of study (18 h),
rats had access only to water. After 18 h from treatment, rats
were euthanized and blood was  collected. The blood samples were
immediately centrifuged (2500 rpm/10 min) and plasma was used
for lipid analysis.
Biochemical analysis of plasma
The plasma total cholesterol, triacylglycerides and HDL-C
were quantiﬁed using enzymatic kits. LDL-C level was calculated
using the formula of Friedewald et al. (1972): LDL-C = TC − (HDL-
C − TG/5).
Effect of friedelin on high-fat diet-induced hyperlipidemic rats
Induction of hyperlipidemia
The hypolipidemic effect of friedelin was studied in high-
fat diet-induced hyperlipidemic rats. Male Wistar rats weighing
180–200 g were used in this study. The rats were fed with a high-fat
diet composed of standard rat chow-68%, dalda (saturated fat)-30%
and cholesterol-2% for 15 days (Guido and Joseph, 1992).
The rats were divided into ﬁve groups of six rats. Group I and
Groups II–V were fed continuously with normal pellet and high-fat
diet, respectively for 28 days.
Group I normal control rats were treated with vehicle alone;
Group II hyperlipidemic control rats were treated with vehicle
alone;
Group III and IV hyperlipidemic rats were treated with friedelin
at 50 and 70 mg/kg, respectively.
Group V hyperlipidemic rats were treated with fenoﬁbrate
(65 mg/kg).
Friedelin (1) and fenoﬁbrate were given once daily continuously
for 28 days, orally. On days 0, 7, 14, 21 and 28, the blood samples
were collected by retro-orbital sinus and the TC, TG, HDL-C and
LDL-C levels were measured.
At the end of the study the rats were sacriﬁced, and blood and
liver samples were collected. The liver samples were stored at −70◦
C for the analysis of TC and TG levels.
Biochemical analysis on serum and liver
The TC, TG and HDL-C were quantiﬁed using enzymatic kits. LDL-
C level was  calculated using the formula of Friedewald et al. (1972):
LDL-C = TC − (HDL-C − TG/5).
Statistical analysis
The results were presented as mean ± SEM. Statistical analysis of
all the data obtained was  evaluated using one-way ANOVA followed
by Dunnett’s test (Graph Pad Instat; Version 3.10). The differences
were considered signiﬁcant at p ≤ 0.05.
Results
Acute toxicity studyAcute toxicity study revealed the non-toxic nature of friedelin at
the doses of 300–700 mg/kg. No mortality and behavioral alterna-
tions were observed in friedelin treated rats. There was no lethality
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Table  1
Effect of friedelin on triton-induced hyperlipidemic model.
Groups Total cholesterol (mg/dl) Triacylglycerides (mg/dl) LDL-C (mg/dl) HDL-C (mg/dl)
Normal control 75.34 ± 7.63** 124.83 ± 5.48** 60.37 ± 6.38** 0.65 ± 0.01**
Triton 301.35 ± 9.38 734.38 ± 2.38 150.73 ± 14.29 0.30 ± 0.03
Triton  + friedelin (30 mg/kg) 333.47 ± 22.39 702.37 ± 6.48 130.26 ± 11.28 0.35 ± 0.03
Triton  + friedelin (50 mg/kg) 233.12 ± 2.38** 443.83 ± 7.38** 90.12 ± 5.60** 0.50 ± 0.02**
Triton + friedelin (70 mg/kg) 204.73 ± 4.10** 403.04 ± 9.39** 72.85 ± 3.94** 0.57 ± 0.06**
Triton + fenoﬁbrate (65 mg/kg) 154.51 ± 9.32** 209.52 ± 4.10** 65.92 ± 4.34** 0.61 ± 0.02**
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Nalues are mean ± SEM (n = 6).
** p < 0.01, compared with hyperlipidemic control values.
r toxic reaction found at any selected dose until the end of the
tudy.
ffect of friedelin on triton-induced hyperlipidemia
The plasma TC, TG, LDL-C and HDL-C levels of friedelin (50 and
0 mg/kg) treated groups are shown in Table 1. In comparison
ith the normal control group, triton caused a marked increase
n plasma TC, TG and LDL-C, and decrease in HDL-C levels. After
reatment with friedelin (50 and 70 mg/kg) there was a signiﬁcant
eduction in the levels of TC (p < 0.01), TG (P < 0.01), and LDL-C
p < 0.01) and increase in the level of HDL-C (p < 0.01). Friedelin
30 mg/kg) showed less effect.
ffect of friedelin on high-fat diet-induced hyperlipidemia
The plasma TC, TG, LDL-C and HDL-C levels of friedelin (50 and
0 mg/kg) treated groups on day 0, 7, 14, 21 and 28 are shown in
able 2. The normal rats fed with high-fat diet for 15 days showed
ncreased plasma TC, TG and LDL-C, and decreased HDL-C lev-
ls. After treatment with friedelin for 28 days the plasma levels
f TC (p < 0.01), TG (p < 0.01), and LDL-C (P < 0.01) were signiﬁ-
antly reduced and the levels of HDL-C (p < 0.01) were signiﬁcantly
ncreased.
The levels of liver TC and TG of normal and hyperlipidemic rats
re shown in Fig. 1. The normal rats fed with fat for 15 days showed
able 2
ffect of friedelin on serum total cholesterol, triacylglycerides, LDL-C and HDL-C of contro
Parameter Groups 0 day 7th day 
TC NC 80.83 ± 3.24 84.73 ±
HC 140.82 ± 2.38 147.86 ±
HC  + friedelin (50 mg/kg) 152.75 ± 4.58 147.84 ±
HC + friedelin (70 mg/kg) 149.64 ± 3.80 132.54 ±
HC + fenoﬁbrate (65 mg/kg) 145.74 ± 7.39 124.40 ±
TG NC 107.53 ± 5.41 103.83 ±
HC 206.30 ± 4.02 353.37 ±
HC  + friedelin (50 mg/kg) 350.83 ± 3.20 332.93 ±
HC + friedelin (70 mg/kg) 340.18 ± 12.68 310.93 ±
HC + fenoﬁbrate (65 mg/kg) 336.73 ± 5.93 315.83 ±
LDL-
C
NC 50.74 ± 1.41 52.52 ±
HC 105.26 ± 4.73 110.33 ±
HC  + friedelin (50 mg/kg) 126.38 ± 3.72 111.73 ±
HC + friedelin (70 mg/kg) 132.85 ± 3.84 120.85 ±
HC + fenoﬁbrate (65 mg/kg) 125.04 ± 3.48 98.59 ±
HDL-
C
NC 40.36 ± 2.84 42.93 ±
HC 30.63 ± 5.48 25.47 ±
HC  + friedelin (50 mg/kg) 32.37 ± 3.48 37.39 ±
HC  + friedelin (70 mg/kg) 35.67 ± 3.47 41.84 ±
HC+ Fenoﬁbrate (65 mg/kg) 36.23 ± 1.02 39.48 ±
alues are mean ± SEM (n = 6).
* p < 0.05, compared with hyperlipidemic control values.
** p < 0.01, compared with hyperlipidemic control values.
C: normal control, HC: hyperlipidemic control.a signiﬁcant increase (p < 0.01) in TC and TG levels of liver. After
treatment with friedelin (50 and 70 mg/kg) the TC and TG levels of
liver reduced to normal.
Discussion
In the present study, we investigated the hypolipidemic effect
of friedelin on Triton WR-1339- and high-fat diet-induced mod-
els. Triton WR-1339, a non-ionic detergent (oxyethylated tertiary
octylphenol formaldehyde polymer), provokes acute hyperlipi-
demia, and thus it has been widely used as a hyperlipidemia
inducing agent to study lipid metabolism and the metabolic inter-
relationship between plasma lipoproteins (Zarzecki et al., 2014;
Ghatak and Panchal, 2012). It induces hyperlipidemia by increas-
ing hepatic cholesterol biosynthesis through its interference with
the tissue uptake of plasma lipids and its inhibition of cholesterol
excretion, and by preventing or delaying the plasma clearance (Jo
et al., 2014). Inhibitory effects on cholesterol biosynthesis occurred
in an earlier study within the ﬁrst 24 h of triton treatment, and the
inhibition of cholesterol metabolism and excretion was  exhibited
after 24 h of triton treatment (Harnaﬁ et al., 2008). In our study,
we evaluated the hypolipidemic activity of friedelin (30, 50 and
70 mg/kg) on triton-induced hyperlipidemic rats. Among the three
doses, 50 and 70 mg/kg showed signiﬁcant effects by decreased
serum lipid levels and increased HDL-C levels in Triton WR-1339-
induced hyperlipidemic rats. This indicates that friedelin altered
l and treated rats on 0, 7th, 14th, 21st and 28th day of high-fat diet-induced model.
14th day 21st day 28th day
 3.28** 90.74 ± 4.95** 93.43 ± 3.28** 90.45 ± 5.49**
 5.74 167.83 ± 6.58 175.48 ± 9.58 190.74 ± 8.47
 7.49 134.53 ± 4.55 124.03 ± 8.41 120.08 ± 6.52**
 5.38 123.93 ± 8.47** 120.38 ± 0.33** 110.34 ± 5.49**
 3.74* 110.30 ± 3.21** 105.12 ± 6.32** 96.26 ± 5.35**
 3.24** 100.73 ± 9.42** 96.48 ± 3.23** 102.12 ± 5.46**
 12.72 362.37 ± 3.63 364.74 ± 6.83 370.93 ± 5.39
 6.48 321.30 ± 4.32** 283.43 ± 10.21** 262.37 ± 4.31**
 8.28** 300.23 ± 5.49** 270.54 ± 11.83** 254.83 ± 0.62**
 27.37** 301.82 ± 3.12** 262.73 ± 12.56** 221.34 ± 9.74**
 3.84** 54.83 ± 6.38** 55.49 ± 7.48** 53.64 ± 2.37**
 5.48 122.38 ± 8.49 130.48 ± 7.39 1132.12 ± 2.93
 3.12 108.27 ± 5.48 102.64 ± 5.99** 100.33 ± 7.49**
 6.51 110.32 ± 5.46* 100.39 ± 3.42** 97.58 ± 6.50**
 2.94** 90.49 ± 4.39** 84.39 ± 3.24** 85.11 ± 9.45**
 3.28** 40.92 ± 5.93** 41.88 ± 3.64** 38.93 ± 4.39**
 9.48 19.38 ± 6.48 15.84 ± 0.39 13.38 ± 1.39
 6.59* 40.95 ± 5.49* 43.58 ± 9.68** 45.45 ± 0.23*,**
 2.83** 43.11 ± 2.11** 45.83 ± 4.38** 46.38 ± 5.23**
 5.23** 40.37 ± 7.12** 42.73 ± 6.84** 48.66 ± 3.12**
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Cig. 1. Effect of friedelin on liver total cholesterol and triacylglyceride levels in ra
*p  < 0.01, compared with hyperlipidemic control values. NC: normal control, HC: h
he cholesterol biosynthesis in the liver in the favor of “good” HDL-
.
A number of studies in the past have also shown that a diet
ith high-fat content caused a considerable increase in the serum
holesterol and triacylglyceride concentrations in rats and mice
Ban et al., 2012). High levels of TC and more importantly LDL
holesterol are major coronary risk factors (Huang et al., 2008). LDL
arries cholesterol from the liver to the peripheral cells and smooth
uscle cells of the arteries; a rise in LDL may  cause deposition of
holesterol in the arteries and aorta and hence is bad for health and
 direct risk factor for coronary heart disease (De Graat et al., 2002).
dministration of friedelin (50 and 70 mg/kg) lowered both TC and
DL cholesterol in experimental rats. The lowering of TC and LDL-C
n serum would reduce the incidence of coronary events (Verma
t al., 2012).
Friedelin showed protective action on high-fat diet-induced
yperlipidemic rats, as it signiﬁcantly increased the serum HDL-
holesterol levels. The possible mechanism of this activity may  be
ue to enhancement of the activity of lecithin–cholesterol acyl-
ransferase and inhibition of the action of hepatic TG-lipase on HDL,
hich may  contribute for a rapid catabolism of blood lipids through
xtra-hepatic tissues. The increased HDL facilitates the transport
f triacylglyceride or cholesterol from serum to liver by a pathway
ermed ‘reverse cholesterol transport’ where it is catabolised and
xcreted out of the body (Srinivasa Rao and Saileela, 2013).
Triacylglycerides play a key role in the regulation of lipoprotein
nteractions to maintain normal lipid metabolism. Recent stud-
es also showed that triacylglycerides are independently related to
oronary heart disease (Noorani et al., 2011) and most of the antihy-
ercholesterolemic drugs do not decrease triacylglycerides levels,
ut friedelin lowered it signiﬁcantly and this effect might be related
o increase in the endothelium bound lipoprotein lipase which
ydrolyses the triacylglycerides into fatty acids (Vembu et al.,
012). Previous study by Jiao et al., 2007 reported that friedelin
solated from bamboo shavings reduced the serum TC, TG, and LDL-
 levels but there was no effect in increasing the HDL-C levels in
iet-induced hyperlipidemic Sprague–Dawley rats. But in both our
tudies friedelin decreased the TC, TG, and LDL-C and increased the
DL-C levels signiﬁcantly.
In conclusion, the present study demonstrated that friedelin
ossessed maximum efﬁcacy in lowering the elevated lipid levels
n Triton WR-1339 and high-fat diet-induced hyperlipidemic rats.
his investigation revealed that friedelin isolated from A. tetracan-
ha leaves could be probed further to be used as a drug to treat
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